EXPERT OPINION ON EMERGING DRUGS

期刊信息导读

1. EXPERT OPINION ON EMERGING DRUGS基本信息
• 2018-2019最新影响因子
• 研究方向
• 官方网站
• 年文章数
2. EXPERT OPINION ON EMERGING DRUGS中科院SCI期刊分区
3. 历年EXPERT OPINION ON EMERGING DRUGS影响因子趋势图
4. EXPERT OPINION ON EMERGING DRUGS期刊英文简介
5. EXPERT OPINION ON EMERGING DRUGS期刊中文简介

EXPERT OPINION ON EMERGING DRUGS基本信息

简称：EXPERT OPIN EMERG DR

中文名称：关于新兴药物的专家意见

研究方向：医学

2018-2019最新影响因子：3.23

SCI类别：SCIE

是否OA开放访问：No

出版地：ENGLAND

出版周期：Quarterly

创刊年份：2001

年文章数：28

涉及的研究方向：医学-药学

通讯方式：INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

官方网站：http://www.tandfonline.com/loi/iemd20

审稿速度：>12周，或约稿

平均录用比例:较易

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8214%5BISSN%5D

EXPERT OPINION ON EMERGING DRUGS期刊英文简介

Expert Opinion on Emerging Drugs provides an expert assessment of the most rapidly advancing drug classes and therapeutic areas. Emerging Drugs profiles, prepared by leading experts, are authoritative, comprehensive and up-to date. Expert Opinion on Emerging Drugs is essential reading for pharmaceutical and academic scientists, research planners, pharmaceutical product mangers, clinical opinion leaders and healthcare planners. Expert Opinion on Emerging Drugs was devised with the intention of providing an expert evaluation of the most important emerging drug technologies. These are assessed in terms of their potential impact on the current management of specific diseases. Expert Opinion on Emerging Drugs also includes papers on Emerging Drug Development Strategies, which aim to provide an accessible and independent assessment of the commercial and technical viability of the most promising areas of drug research.

EXPERT OPINION ON EMERGING DRUGS期刊中文简介

关于新兴药物的专家意见提供了最快速发展的药物类别和治疗领域的专家评估。由主要专家编写的新兴药物简介是权威的、全面的和最新的。新兴药物的专家意见是必不可少的阅读医药和学术科学家，研究规划，医药产品经理，临床意见领袖和医疗保健规划。制定关于新兴药物的专家意见的目的是对最重要的新兴药物技术提供专家评价。这些评估是根据它们对当前特定疾病管理的潜在影响。关于新兴药物的专家意见还包括关于新兴药物发展战略的论文，其目的是对最有希望的药物研究领域的商业和技术可行性提供一种可获得和独立的评估。

中科院SCI期刊分区：

EXPERT OPINION ON EMERGING DRUGS影响因子

获取相关优质资源获取2023中科院分区